Medical School · Year 2 · Pathology · includes a quiz and discussion video

Lecture 8: Environmental and Nutritional Pathology

Unit 2.11: Pathology

Learning Objectives

By the end of this lecture, students will be able to:

1. Describe the pathologic effects of common environmental toxins
2. Explain alcohol-related diseases
3. Describe smoking-related pathology
4. Explain drug-induced tissue injury
5. Describe nutritional deficiencies and their consequences
6. Explain obesity and its complications

Lecture Outline

I. Environmental Toxins - Overview

Environmental toxins enter the human body through multiple routes of exposure, each presenting unique challenges for absorption, distribution, and ultimate tissue damage. Inhalation represents one of the most common routes, allowing air pollutants, gases, and particulate matter to directly access the respiratory epithelium and subsequently enter the systemic circulation. Ingestion of contaminated water or food introduces toxins through the gastrointestinal tract, where absorption depends on solubility, pH, and the presence of transporters. Dermal exposure occurs with occupational and household chemicals, while injection, particularly associated with intravenous drug use, bypasses all natural barriers to deliver toxins directly into the bloodstream.

The toxicity of any substance depends on multiple factors that determine its ultimate impact on tissues and organs. Dose represents the fundamental determinant, with higher doses generally producing more severe effects following established dose-response relationships. Duration of exposure differentiates acute toxicity, occurring within hours to days, from chronic toxicity developing over months to years with cumulative damage. The route of exposure affects bioavailability, as substances absorbed through the lungs often achieve higher systemic levels than those traversing the gastrointestinal tract with its first-pass hepatic metabolism.

Individual factors profoundly influence susceptibility to environmental toxins and the severity of resulting disease. Metabolism represents a critical variable, as cytochrome P450 enzymes may either detoxify substances or activate them to more toxic intermediates. Genetic polymorphisms in metabolizing enzymes create significant interindividual variation in toxin susceptibility, explaining why some individuals develop disease while others with similar exposures remain unaffected. Age affects vulnerability, with developing fetuses and young children particularly susceptible due to immature detoxification systems and ongoing organogenesis, while elderly individuals may have diminished repair capacity and accumulated prior damage.

The mechanisms by which environmental toxins produce cellular injury encompass several distinct pathways. Free radical generation occurs with substances like carbon tetrachloride, which undergoes hepatic metabolism to reactive species that attack membrane lipids through peroxidation. Direct chemical damage from strong acids and bases denatures proteins and disrupts membranes without requiring metabolic activation. Heavy metals inhibit essential enzymes by binding to sulfhydryl groups, while carcinogens produce DNA damage leading to mutations and eventual malignancy. Immune-mediated injury occurs when toxins or their metabolites act as haptens, triggering hypersensitivity reactions that may exceed the direct toxic effects.

<image>Panel A: Routes of environmental toxin exposure showing inhalation pathway with particles depositing in airways and alveoli, absorption across respiratory epithelium into pulmonary capillaries. Panel B: Dose-response curve demonstrating threshold dose, linear portion, and plateau, with comparison of substances showing different slopes indicating varying potencies. Panel C: Hepatic metabolism diagram showing Phase I oxidation by cytochrome P450 and Phase II conjugation, illustrating both detoxification and bioactivation pathways. Panel D: Cellular injury mechanisms with free radical attacking membrane phospholipids, heavy metal binding to enzyme sulfhydryl groups, and carcinogen-DNA adduct formation.</image>

II. Air Pollution and Pneumoconioses

Air pollution encompasses a complex mixture of gaseous and particulate pollutants that produce significant respiratory and cardiovascular morbidity and mortality. Particulate matter, classified by aerodynamic diameter as PM10 (less than 10 micrometers) and PM2.5 (less than 2.5 micrometers), penetrates the respiratory tract to varying depths, with smaller particles reaching the alveoli and even translocating into the systemic circulation. Ozone, a powerful oxidant formed by photochemical reactions in the lower atmosphere, produces airway inflammation and exacerbates asthma through direct epithelial damage. Carbon monoxide binds hemoglobin with 200-fold greater affinity than oxygen, producing tissue hypoxia even at relatively low atmospheric concentrations. Sulfur dioxide and nitrogen dioxide both cause bronchoconstriction and airway inflammation, contributing to increased respiratory symptoms in exposed populations.

Pneumoconioses represent a group of occupational lung diseases caused by inhalation and retention of mineral dusts, with disease severity determined by particle characteristics and cumulative exposure. Particle size critically determines the anatomic site of deposition, with particles between 1 and 5 micrometers reaching the terminal airways and alveoli where they produce the most significant pathology. Solubility influences clearance, as highly soluble particles dissolve and clear rapidly while insoluble particles persist and trigger ongoing inflammation. The fibrogenic potential varies among different particles, with silica producing intense fibrosis while coal dust generates a more modest fibrotic response at equivalent exposures.

Coal worker's pneumoconiosis develops in miners exposed to coal dust, progressing through distinct stages of increasing severity and disability. Simple coal worker's pneumoconiosis manifests as coal macules, consisting of dust-laden macrophages surrounding respiratory bronchioles, which may be visible on chest radiography as small nodular opacities. Progressive massive fibrosis represents the advanced stage, with large fibrotic masses typically located in the upper lobes, often containing necrotic centers that may cavitate. Caplan syndrome describes the unusual occurrence of large rheumatoid nodules in the lungs of coal workers with rheumatoid arthritis, reflecting the interaction between dust exposure and autoimmune disease.

Silicosis results from inhalation of crystalline silica, most commonly in occupations such as sandblasting, mining, and stone cutting, with a characteristically fibrotic pattern. The silicotic nodule represents the pathologic hallmark, consisting of whorled collagen fibers surrounding a central area of acellular hyalinization, typically distributed in the upper lung zones. Hilar lymph node involvement produces the distinctive eggshell calcification pattern visible radiographically, representing calcified rims around nodal peripheries. Silicosis increases susceptibility to tuberculosis, a complication termed silicotuberculosis, reflecting impaired macrophage function in the silica-laden lung. The intense fibrogenic response to silica particles results from their cytotoxic effect on alveolar macrophages, which release fibrogenic cytokines as they die and are replaced by successive waves of phagocytic cells.

<image>Panel A: Particulate matter deposition in respiratory tract showing PM10 depositing in upper airways, PM2.5 reaching alveoli, and ultrafine particles translocating across alveolar epithelium into capillaries. Panel B: Coal worker's pneumoconiosis progression from coal macule with dust-laden macrophages around bronchiole, to simple CWP with multiple small nodules, to progressive massive fibrosis with large upper lobe mass. Panel C: Silicotic nodule microscopic appearance with concentric whorled collagen layers, central hyalinization, and surrounding dust-laden macrophages. Panel D: Chest radiograph pattern showing upper lobe nodular opacities of silicosis with characteristic eggshell calcification of hilar lymph nodes.</image>

III. Asbestos-Related Disease and Heavy Metal Toxicity

Asbestos exposure produces a spectrum of diseases affecting both the pleura and lung parenchyma, with manifestations depending on fiber type, dose, and duration of exposure. Asbestosis refers specifically to interstitial pulmonary fibrosis caused by asbestos, typically affecting the lower lobes and progressing from mild fibrosis to honeycombing in advanced cases. The pathologic hallmark is the ferruginous body, representing an asbestos fiber coated with iron-containing protein, which appears as a golden-brown beaded structure on microscopy. Pleural plaques are benign fibrous lesions on the parietal pleura that often calcify, serving as markers of asbestos exposure but not progressing to malignancy. The latency period between exposure and disease development typically spans 20 to 40 years, complicating exposure assessment and requiring detailed occupational histories.

Malignant mesothelioma represents the signature malignancy of asbestos exposure, arising from mesothelial cells lining the pleura, peritoneum, or pericardium. The tumor grows as a thick rind encasing the lung, often presenting with pleural effusion, chest pain, and progressive dyspnea. Mesothelioma demonstrates a striking association with amphibole asbestos fibers, particularly crocidolite, which are more fibrogenic and carcinogenic than the more common chrysotile serpentine fibers. The combination of asbestos exposure and cigarette smoking multiplicatively increases lung cancer risk approximately 50-fold compared to non-smoking unexposed individuals, demonstrating powerful carcinogenic synergy.

Lead poisoning affects multiple organ systems with manifestations varying by age, exposure level, and duration, representing one of the most extensively studied environmental toxicoses. In children, even low blood lead levels produce cognitive impairment, behavioral problems, and reduced IQ, as the developing nervous system demonstrates particular vulnerability. Adults typically manifest peripheral neuropathy affecting motor nerves, classically producing wrist drop, along with abdominal colic that may mimic surgical conditions. Hematologic effects include microcytic anemia resulting from inhibited heme synthesis, with peripheral blood smear revealing the characteristic basophilic stippling of red blood cells reflecting impaired ribosomal degradation. Lead lines on radiographs of long bones in children reflect increased lead deposition at the metabolically active growth plates.

Mercury toxicity varies dramatically depending on the chemical form, with organic methylmercury producing the most severe neurologic damage. Methylmercury accumulates through the food chain, reaching highest concentrations in large predatory fish, and crosses both the blood-brain barrier and placenta to damage neurons. Minamata disease, first recognized in Japan in the 1950s, resulted from industrial mercury contamination of Minamata Bay, producing devastating neurologic damage in affected fishing communities and their offspring. Arsenic, another significant environmental toxin, produces characteristic skin changes including hyperpigmentation, hyperkeratosis of palms and soles, and distinctive Mees lines across fingernails. Chronic arsenic exposure is associated with increased risk of skin, lung, and bladder cancers, making it one of the most important environmental carcinogens in regions with contaminated groundwater.

<image>Panel A: Ferruginous body microscopic image showing golden-brown beaded structure with iron-coated asbestos fiber core, surrounded by alveolar macrophages in fibrotic lung tissue. Panel B: Malignant mesothelioma gross specimen with thick tumor rind encasing and constricting lung, obliterating pleural space and invading chest wall. Panel C: Lead poisoning pathophysiology diagram showing inhibition of heme synthesis enzymes (delta-ALA dehydratase, ferrochelatase), effects on neurons, and basophilic stippling in red blood cells. Panel D: Arsenic toxicity skin manifestations including palmar hyperkeratosis, diffuse hyperpigmentation with raindrop depigmentation pattern, and transverse Mees lines on fingernails.</image>

IV. Alcohol-Related Diseases

Alcohol metabolism occurs predominantly in the liver through two sequential enzymatic steps that generate both energy and toxic intermediates. Alcohol dehydrogenase catalyzes the first step, oxidizing ethanol to acetaldehyde while reducing NAD+ to NADH, fundamentally altering the hepatocyte redox state. Aldehyde dehydrogenase subsequently converts the highly reactive acetaldehyde to acetate, completing detoxification; genetic variants in this enzyme, common in Asian populations, produce accumulation of acetaldehyde causing the characteristic facial flushing reaction. With chronic heavy drinking, the microsomal ethanol oxidizing system utilizing CYP2E1 becomes induced, providing an alternate pathway that generates reactive oxygen species as byproducts. The combined effects of acetaldehyde toxicity, redox imbalance from NADH accumulation, and oxidative stress from CYP2E1 activity drive the progression of alcoholic liver disease.

Alcoholic liver disease progresses through a characteristic spectrum beginning with fatty liver, advancing to alcoholic hepatitis, and potentially culminating in cirrhosis. Alcoholic steatosis, or fatty liver, results from NADH accumulation that shifts metabolism toward lipid synthesis while inhibiting fatty acid oxidation, producing macrovesicular fat accumulation in hepatocytes. This initial stage is completely reversible with abstinence, as hepatocytes clear accumulated lipids when normal metabolism resumes. The prevalence of steatosis approaches 90% in heavy drinkers, making it nearly universal among those consuming toxic quantities of alcohol.

Alcoholic hepatitis represents a more severe inflammatory stage characterized by distinctive pathologic features and significant clinical morbidity and mortality. Mallory-Denk bodies, the histologic hallmark, appear as eosinophilic cytoplasmic inclusions composed of ubiquitinated cytokeratin aggregates within damaged hepatocytes. Ballooning degeneration describes the swollen, pale appearance of injured hepatocytes, often surrounded by neutrophils in a pattern termed satellitosis. Clinical presentation typically includes fever, jaundice, hepatomegaly, and laboratory findings demonstrating AST elevation exceeding ALT, typically in a 2:1 ratio distinguishing alcoholic from other forms of hepatitis. Severe alcoholic hepatitis carries mortality exceeding 50% at one month, establishing it as a life-threatening condition requiring intensive management.

Alcohol affects virtually every organ system beyond the liver, producing a constellation of diseases that significantly increase morbidity and mortality. Chronic pancreatitis results from repeated episodes of acute pancreatitis, with alcohol representing the leading cause in developed countries. Alcoholic cardiomyopathy manifests as dilated cardiomyopathy with reduced ejection fraction, resulting from direct toxic effects on cardiac myocytes. Wernicke-Korsakoff syndrome results from thiamine deficiency secondary to both poor nutritional intake and impaired absorption in alcoholics, producing acute confusion, ophthalmoplegia, and ataxia (Wernicke encephalopathy) that may progress to permanent anterograde amnesia (Korsakoff syndrome). Fetal alcohol syndrome represents the devastating consequence of maternal drinking during pregnancy, producing characteristic facial features, growth retardation, and irreversible cognitive impairment in affected offspring.

<image>Panel A: Alcohol metabolism pathway diagram showing alcohol dehydrogenase converting ethanol to acetaldehyde with NAD+ to NADH, aldehyde dehydrogenase converting acetaldehyde to acetate, and CYP2E1 pathway generating reactive oxygen species. Panel B: Alcoholic liver disease spectrum showing normal liver progressing to fatty liver with macrovesicular steatosis, to alcoholic hepatitis with Mallory bodies and neutrophilic infiltrate, to cirrhosis with regenerative nodules and fibrosis. Panel C: Mallory-Denk body microscopic appearance as eosinophilic, rope-like cytoplasmic inclusion within ballooned hepatocyte surrounded by neutrophils. Panel D: Systemic effects of chronic alcoholism showing dilated cardiomyopathy, chronic pancreatitis with calcifications, and brain atrophy with mammillary body changes of Wernicke-Korsakoff syndrome.</image>

V. Tobacco-Related Diseases

Cigarette smoke contains over 4,000 chemical compounds, including more than 60 proven carcinogens that produce DNA damage through multiple mechanisms. Polycyclic aromatic hydrocarbons, formed during tobacco combustion, require metabolic activation by cytochrome P450 enzymes to generate reactive intermediates that form DNA adducts. Tobacco-specific nitrosamines, derived from nicotine during curing and smoking, represent potent carcinogens particularly associated with lung adenocarcinoma. Aromatic amines in cigarette smoke contribute to bladder cancer risk by undergoing hepatic activation followed by renal excretion, producing carcinogen exposure to urothelium. Heavy metals including cadmium and arsenic accumulate in smokers, adding to the carcinogenic burden and contributing to systemic toxicity.

Lung cancer demonstrates the strongest association with cigarette smoking, with smokers bearing 10 to 20-fold increased risk compared to never-smokers in a clear dose-response relationship. The risk correlates with pack-years of smoking, representing the product of packs per day multiplied by years of smoking, with higher cumulative exposure producing proportionally greater risk. All histologic types of lung cancer occur with increased frequency in smokers, although squamous cell carcinoma and small cell carcinoma show the strongest smoking associations. Smoking cessation gradually reduces risk, although former smokers retain elevated risk compared to never-smokers for 10 to 15 years, and some excess risk may persist indefinitely. Second-hand smoke exposure increases lung cancer risk in non-smokers by approximately 20 to 30%, establishing environmental tobacco smoke as a significant public health hazard.

Chronic obstructive pulmonary disease encompasses emphysema and chronic bronchitis, both overwhelmingly associated with cigarette smoking in developed countries. Emphysema results from protease-antiprotease imbalance, as cigarette smoke recruits neutrophils to the lung while inactivating alpha-1 antitrypsin, permitting uncontrolled elastase activity that destroys alveolar walls. The centrilobular pattern of emphysema, affecting the respiratory bronchioles while sparing distal alveoli, typically predominates in smokers and preferentially involves upper lung zones. Chronic bronchitis, defined clinically by productive cough for at least three months in two consecutive years, results from goblet cell hyperplasia and mucus hypersecretion in response to chronic irritation. The combination of airflow obstruction from both emphysema and bronchitis produces progressive dyspnea, reduced exercise tolerance, and ultimately respiratory failure.

Cardiovascular disease represents a major contributor to smoking-related mortality, with smokers experiencing significantly increased risk of atherosclerosis, myocardial infarction, and stroke. Smoking promotes atherogenesis through multiple mechanisms including endothelial dysfunction, platelet activation, oxidation of LDL cholesterol, and direct toxic effects on vascular smooth muscle. Nicotine acts as a sympathomimetic, increasing heart rate and blood pressure while promoting coronary vasoconstriction. Carbon monoxide reduces oxygen-carrying capacity while increasing carboxyhemoglobin levels, producing relative tissue hypoxia that compounds the cardiovascular burden. Peripheral arterial disease occurs with increased frequency and severity in smokers, with Buerger disease (thromboangiitis obliterans) occurring almost exclusively in young male smokers.

<image>Panel A: Carcinogen pathway showing polycyclic aromatic hydrocarbon activation by CYP1A1 to reactive epoxide forming DNA adduct with guanine base. Panel B: Emphysema pathophysiology with cigarette smoke recruiting neutrophils that release elastase while oxidants inactivate alpha-1 antitrypsin, resulting in alveolar wall destruction with centrilobular pattern. Panel C: Chronic bronchitis histology showing thickened bronchial wall with goblet cell hyperplasia, mucous gland enlargement (increased Reid index), squamous metaplasia, and chronic inflammatory infiltrate. Panel D: Smoking-related cardiovascular changes including atherosclerotic plaque with lipid core and fibrous cap, endothelial dysfunction with reduced nitric oxide, and platelet aggregation on damaged endothelium.</image>

VI. Drug-Induced Tissue Injury

Drug-induced tissue injury occurs through multiple mechanisms ranging from predictable dose-dependent toxicity to unpredictable idiosyncratic reactions mediated by immune mechanisms. Direct toxicity follows pharmacologic principles, with higher doses producing more severe injury through mechanisms that are extensions of the drug's therapeutic effects. Metabolism plays a crucial role, as hepatic biotransformation may generate reactive intermediates more toxic than the parent compound, a process termed bioactivation. Idiosyncratic reactions occur unpredictably, affecting only susceptible individuals regardless of dose, and often involve immune-mediated mechanisms where drug or metabolite acts as a hapten.

Acetaminophen toxicity represents the classic example of predictable, dose-dependent hepatotoxicity mediated by a reactive metabolite. At therapeutic doses, acetaminophen undergoes glucuronidation and sulfation, producing water-soluble conjugates excreted by the kidneys. When these pathways become saturated with overdose, metabolism shifts to cytochrome P450-mediated oxidation generating N-acetyl-p-benzoquinone imine, known as NAPQI, an extremely reactive compound. Glutathione normally conjugates NAPQI, but when glutathione stores become depleted, unconjugated NAPQI covalently binds hepatocyte proteins, producing centrilobular necrosis affecting the perivenular zone 3 hepatocytes where CYP2E1 concentration is highest. N-acetylcysteine serves as the antidote by replenishing glutathione stores, but effectiveness diminishes if administration is delayed beyond 8 to 10 hours after ingestion.

Drug-induced liver injury encompasses diverse patterns that may resemble virtually any primary liver disease, creating significant diagnostic challenges. The hepatocellular pattern demonstrates predominantly elevated aminotransferases with modest alkaline phosphatase elevation, resembling viral hepatitis or autoimmune hepatitis. Cholestatic drug reactions produce elevated alkaline phosphatase and bilirubin with lesser transaminase elevation, mimicking biliary obstruction. Mixed patterns show features of both hepatocellular injury and cholestasis, while some drugs produce distinctive lesions such as sinusoidal obstruction syndrome (formerly veno-occlusive disease) or bland cholestasis. Latency between drug initiation and injury varies from days with direct hepatotoxins to months with immune-mediated reactions, requiring careful medication history review.

Drug toxicity affects multiple organs beyond the liver, with patterns that clinicians must recognize to prevent continued exposure. Non-steroidal anti-inflammatory drugs produce multiple forms of kidney injury including acute interstitial nephritis, characterized by fever, rash, and eosinophilia, and hemodynamically-mediated acute kidney injury from prostaglandin inhibition. Methotrexate produces cumulative hepatotoxicity leading to fibrosis and cirrhosis, requiring monitoring of cumulative dose and periodic liver assessment. Amiodarone, a highly lipophilic antiarrhythmic, accumulates in multiple organs producing pulmonary fibrosis, hepatotoxicity resembling alcoholic hepatitis, and thyroid dysfunction. Anthracycline chemotherapeutic agents such as doxorubicin cause cumulative, dose-dependent cardiotoxicity leading to dilated cardiomyopathy through free radical generation and topoisomerase inhibition in cardiomyocytes.

<image>Panel A: Acetaminophen metabolism diagram showing therapeutic pathway through glucuronidation and sulfation, toxic pathway through CYP2E1 to NAPQI, glutathione conjugation for detoxification, and protein adduct formation when glutathione depleted. Panel B: Centrilobular hepatic necrosis pattern with preservation of periportal hepatocytes (zone 1) and complete necrosis of perivenular zone 3, corresponding to highest CYP2E1 concentration. Panel C: Drug-induced liver injury patterns comparing hepatocellular (high AST/ALT, low ALP), cholestatic (low AST/ALT, high ALP and bilirubin), and mixed patterns. Panel D: Multi-organ drug toxicity showing NSAID-induced acute interstitial nephritis with eosinophilic infiltrate, amiodarone pulmonary toxicity with foamy macrophages, and anthracycline cardiotoxicity with myocyte vacuolization.</image>

VII. Vitamin Deficiencies - Fat-Soluble Vitamins

Fat-soluble vitamins, encompassing vitamins A, D, E, and K, require bile salts for intestinal absorption and can accumulate in body fat stores, producing both deficiency states with inadequate intake and toxicity syndromes with excessive supplementation. Vitamin A functions in vision through its role in rhodopsin, the retinal photopigment, and in epithelial differentiation and maintenance throughout the body. Deficiency manifests first as night blindness, reflecting impaired rod cell function, and progresses to xerophthalmia with conjunctival dryness, Bitot spots appearing as foamy deposits on the conjunctiva, and ultimately corneal ulceration and blindness. Keratomalacia represents the end-stage of ocular vitamin A deficiency, with corneal liquefaction that may produce permanent vision loss. Globally, vitamin A deficiency remains the leading cause of preventable blindness in children, particularly in developing regions with inadequate dietary diversity.

Vitamin D functions as a hormone regulating calcium and phosphate homeostasis through its actions on intestine, bone, and kidney. Deficiency impairs intestinal calcium absorption, producing hypocalcemia that stimulates parathyroid hormone secretion and secondary hyperparathyroidism. In children, vitamin D deficiency produces rickets, characterized by defective mineralization of growth plate cartilage resulting in skeletal deformities including bowed legs, rachitic rosary at costochondral junctions, and craniotabes with soft skull bones. In adults, the equivalent condition is osteomalacia, manifesting as defective mineralization of newly formed osteoid, bone pain, proximal muscle weakness, and increased fracture risk. Vitamin D toxicity from excessive supplementation causes hypercalcemia with consequent metastatic soft tissue calcification, nephrocalcinosis, and nephrolithiasis.

Vitamin E functions primarily as an antioxidant, protecting polyunsaturated fatty acids in cell membranes from lipid peroxidation by reactive oxygen species. Deficiency is rare in humans due to widespread dietary availability but occurs with fat malabsorption syndromes such as abetalipoproteinemia, cystic fibrosis, and cholestatic liver disease. The clinical manifestations reflect damage to tissues with high membrane lipid content, producing spinocerebellar degeneration with ataxia, peripheral neuropathy, and skeletal myopathy. Retinal pigmentary degeneration may also develop, producing progressive visual impairment. Premature infants represent a vulnerable population due to limited placental transfer and low body stores.

Vitamin K is essential for hepatic synthesis of coagulation factors II (prothrombin), VII, IX, and X, as well as proteins C and S, functioning as a cofactor for gamma-carboxylation of glutamic acid residues. Deficiency produces a bleeding diathesis with prolonged prothrombin time, as the vitamin K-dependent factors become non-functional without proper carboxylation. Dietary deficiency alone is unusual in healthy adults due to both dietary sources and bacterial synthesis in the colon, but occurs in newborns who lack established gut flora and receive minimal vitamin K from breast milk, producing hemorrhagic disease of the newborn. Warfarin and related anticoagulants act as vitamin K antagonists, inhibiting the vitamin K epoxide reductase that regenerates the active form of vitamin K after each carboxylation cycle. Malabsorption, biliary obstruction, and prolonged antibiotic therapy disrupting gut flora all predispose to vitamin K deficiency.

<image>Panel A: Vitamin A deficiency ocular progression showing normal conjunctiva, then Bitot spots as foamy triangular deposits, xerosis with dry lusterless cornea, and keratomalacia with corneal ulceration and opacity. Panel B: Vitamin D metabolism and rickets showing 25-hydroxylation in liver, 1-alpha-hydroxylation in kidney, and skeletal manifestations including rachitic rosary, widened wrists, and bowed legs with cupped metaphyses on radiograph. Panel C: Vitamin E deficiency pathology with lipid peroxidation of neuronal membranes producing spinocerebellar tract degeneration, posterior column involvement, and peripheral nerve demyelination. Panel D: Vitamin K-dependent coagulation cascade showing gamma-carboxylation of factors II, VII, IX, X and warfarin inhibition of vitamin K epoxide reductase recycling.</image>

VIII. Vitamin Deficiencies - Water-Soluble Vitamins

Water-soluble vitamins, comprising the B-complex vitamins and vitamin C, are not stored appreciably in the body and require regular dietary intake to prevent deficiency states. Thiamine, vitamin B1, functions as a cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase, enzymes critical for carbohydrate metabolism and the pentose phosphate pathway. Beriberi, the classic thiamine deficiency syndrome, presents in two forms: wet beriberi with high-output cardiac failure and edema, and dry beriberi with peripheral neuropathy predominantly affecting sensory and motor functions of the lower extremities. Wernicke encephalopathy represents acute thiamine deficiency affecting the brain, producing the classic triad of confusion, ophthalmoplegia, and ataxia, with mammillary body and periventricular gray matter lesions. Without treatment, this may progress to Korsakoff syndrome with permanent anterograde amnesia, reflecting irreversible neuronal loss.

Niacin, vitamin B3, is essential for synthesis of NAD and NADP, coenzymes participating in numerous oxidation-reduction reactions throughout cellular metabolism. Pellagra, the niacin deficiency syndrome, classically presents with the four Ds: dermatitis, diarrhea, dementia, and death if untreated. The dermatitis characteristically affects sun-exposed areas, producing the distinctive Casal necklace distribution around the neck, with hyperpigmented, rough, scaly skin resembling sunburn. Pellagra historically affected populations dependent on corn-based diets, as niacin in corn is bound in an unavailable form, and remains prevalent where corn is a dietary staple without proper processing. Hartnup disease, an inherited disorder of tryptophan absorption, can produce pellagra-like symptoms because tryptophan serves as a precursor for endogenous niacin synthesis.

Vitamin B12 (cobalamin) and folate deficiencies produce clinically similar megaloblastic anemias but with distinct neurologic implications and underlying causes. Both vitamins participate in one-carbon metabolism required for DNA synthesis, and their deficiency impairs nuclear maturation while cytoplasmic development continues, producing large abnormal precursors. B12 deficiency results from pernicious anemia with autoimmune destruction of gastric parietal cells, gastrectomy, ileal disease or resection affecting the terminal ileal absorption site, or rarely strict veganism. The critical distinction is that B12 deficiency produces subacute combined degeneration of the spinal cord, affecting both posterior columns and lateral corticospinal tracts, producing sensory ataxia and upper motor neuron signs. Folate deficiency more commonly results from dietary insufficiency, alcoholism, or increased requirements during pregnancy, and neural tube defects in the developing fetus represent the most devastating consequence of maternal folate deficiency.

Vitamin C, ascorbic acid, functions as an essential cofactor for prolyl and lysyl hydroxylases, enzymes required for collagen cross-linking and structural stability. Scurvy, the vitamin C deficiency syndrome, produces widespread connective tissue abnormalities reflecting defective collagen. Gingival involvement with swelling, bleeding, and loosening of teeth reflects collagen-rich gingival tissue damage. Perifollicular hemorrhages with corkscrew hairs represent a distinctive cutaneous finding, while poor wound healing results from inability to form stable granulation tissue. Subperiosteal hemorrhages occur in children, producing bone pain and pseudoparalysis. Historical associations with long sea voyages led to the requirement for citrus provisions, though scurvy still occurs in individuals with extremely restricted diets, alcoholics, and the elderly.

<image>Panel A: Thiamine deficiency pathways showing metabolic role in pyruvate dehydrogenase complex, wet beriberi with dilated cardiomyopathy and edema, dry beriberi with peripheral nerve demyelination, and Wernicke encephalopathy with mammillary body hemorrhage. Panel B: Pellagra manifestations including Casal necklace dermatitis on sun-exposed neck with clear demarcation, glossitis with red beefy tongue, and neuropsychiatric changes with confusion progressing to dementia. Panel C: Megaloblastic anemia comparison showing large oval macrocytes and hypersegmented neutrophils in peripheral blood, megaloblastic erythroblasts with nuclear-cytoplasmic asynchrony in marrow, and B12-specific subacute combined degeneration of spinal cord. Panel D: Scurvy clinical features with swollen bleeding gums, perifollicular hemorrhages surrounding corkscrew hairs, ecchymoses from capillary fragility, and impaired wound healing with defective granulation tissue.</image>

IX. Protein-Energy Malnutrition

Protein-energy malnutrition represents the most common and devastating form of undernutrition globally, particularly affecting children in developing regions and contributing significantly to childhood mortality. The two classic forms, marasmus and kwashiorkor, represent extremes of a spectrum, with marasmus resulting from total caloric deficiency and kwashiorkor from predominant protein deficiency despite relatively adequate caloric intake. Mixed forms, termed marasmic-kwashiorkor, are common in clinical practice, reflecting the reality that pure forms are unusual. Understanding the pathophysiology of these conditions informs both diagnosis and the careful refeeding required to avoid complications.

Marasmus results from severe, prolonged total caloric restriction, producing a state of near-complete depletion of body fat and muscle mass. The appearance is striking, with extreme wasting producing a thin, wizened facies and limbs reduced to skin and bones, often described as resembling the very elderly. Fat stores are completely depleted, including subcutaneous fat and buccal fat pads, while muscle mass is severely reduced as protein is catabolized for gluconeogenesis. Despite the severe wasting, serum albumin remains relatively preserved because the liver continues to synthesize albumin from catabolized muscle protein. Edema is characteristically absent, distinguishing marasmus from kwashiorkor, and the child often remains alert and hungry despite the devastating nutritional state.

Kwashiorkor, meaning "displaced child" in the Ghanaian language from which it derives, typically affects young children weaned to a protein-poor, carbohydrate-rich diet when displaced by a subsequent sibling. The cardinal feature is edema, typically beginning in the lower extremities and progressing to involve the face and hands, creating the characteristic puffy appearance. Hepatomegaly results from fatty infiltration, as inadequate protein intake impairs synthesis of apolipoproteins required to export triglycerides from hepatocytes. Skin changes include areas of hyperpigmentation that desquamate, producing a "flaky paint" or "enamel paint" dermatosis. Hair changes include sparse, easily plucked hair that may become reddish or have alternating bands of color reflecting periods of adequate and inadequate nutrition, termed the "flag sign."

The systemic consequences of protein-energy malnutrition extend beyond the obvious wasting to affect virtually every organ system, particularly the immune system. Cell-mediated immunity is severely impaired, with thymic atrophy and reduced T lymphocyte numbers and function, creating profound susceptibility to infections that represent the immediate cause of death in most malnourished children. The gastrointestinal tract demonstrates villous atrophy and reduced absorptive capacity, paradoxically impairing the ability to utilize nutrients when feeding resumes. Cardiac muscle mass decreases along with skeletal muscle, reducing cardiac output and predisposing to heart failure with rapid refeeding. Refeeding syndrome represents a dangerous complication of overly aggressive nutritional rehabilitation, as metabolic shifts from catabolism to anabolism deplete serum phosphate, potassium, and magnesium, potentially producing cardiac arrhythmias and death.

<image>Panel A: Marasmus clinical appearance showing severely wasted child with prominent ribs, absent subcutaneous fat, thin limbs with visible bones, loose wrinkled skin, and sunken buccal fat pads creating aged appearance while remaining alert. Panel B: Kwashiorkor features including pitting edema of lower extremities and face, hepatomegaly from fatty infiltration, distended abdomen, and characteristic flaky paint dermatosis with hyperpigmented desquamating patches. Panel C: Hair changes in malnutrition showing sparse easily plucked hair with flag sign displaying alternating bands of normal pigmentation and reddish discoloration corresponding to nutritional status changes. Panel D: Systemic effects diagram showing thymic atrophy with T cell depletion, intestinal villous atrophy, fatty liver, muscle wasting affecting both skeletal and cardiac muscle.</image>

X. Obesity and Metabolic Complications

Obesity, defined as body mass index of 30 or greater, has reached epidemic proportions globally and represents a major driver of chronic disease including type 2 diabetes, cardiovascular disease, and certain cancers. The fundamental cause is sustained energy imbalance with caloric intake exceeding expenditure, but the pathophysiology involves complex interactions among genetic susceptibility, environmental factors, and hormonal regulation. Twin studies demonstrate heritability of 40 to 70 percent for body mass index, establishing a strong genetic component, while the rapid increase in obesity prevalence reflects environmental changes promoting excess caloric intake and reduced physical activity. The distribution of adipose tissue matters clinically, with visceral (central) obesity carrying greater metabolic risk than subcutaneous (peripheral) obesity.

Adipose tissue functions as an active endocrine organ, secreting adipokines that regulate metabolism, inflammation, and vascular function throughout the body. Leptin, produced proportionally to fat mass, signals satiety to the hypothalamus and should suppress appetite as fat stores increase, but obese individuals develop leptin resistance. Adiponectin, which enhances insulin sensitivity and has anti-inflammatory effects, is paradoxically reduced in obesity, contributing to metabolic dysregulation. Pro-inflammatory cytokines including TNF-alpha and IL-6 are secreted by adipose tissue, particularly visceral fat, creating a chronic low-grade inflammatory state. Macrophage infiltration of adipose tissue increases with obesity, with a shift from anti-inflammatory M2 macrophages to pro-inflammatory M1 macrophages that amplify the inflammatory milieu.

The metabolic syndrome encompasses a cluster of abnormalities including central obesity, dyslipidemia, hypertension, and impaired glucose tolerance that together dramatically increase cardiovascular risk. Insulin resistance represents the central pathophysiologic feature, with adipose tissue inflammation disrupting insulin signaling and producing compensatory hyperinsulinemia. The characteristic dyslipidemia includes elevated triglycerides, reduced HDL cholesterol, and increased small dense LDL particles that are particularly atherogenic. Non-alcoholic fatty liver disease affects the majority of obese individuals, ranging from simple steatosis to steatohepatitis with hepatocyte ballooning and inflammation that may progress to fibrosis and cirrhosis. The term metabolic dysfunction-associated steatotic liver disease has recently been adopted to more accurately reflect the metabolic basis of this condition.

Obesity increases risk for multiple cancers, with particularly strong associations for endometrial, breast (postmenopausal), colon, kidney, and esophageal adenocarcinoma. The mechanisms are multifactorial, involving increased estrogen production from peripheral aromatization in adipose tissue, hyperinsulinemia and elevated insulin-like growth factor levels, and chronic inflammation. Mechanical complications include obstructive sleep apnea from upper airway obstruction, obesity hypoventilation syndrome with chronic hypercapnia, and accelerated osteoarthritis from increased joint loading. Surgical risk is increased, with more difficult procedures, delayed wound healing, and increased rates of venous thromboembolism. The psychosocial burden of obesity includes depression, social stigmatization, and reduced quality of life, creating additional barriers to successful weight management.

<image>Panel A: BMI classification scale with normal (18.5-24.9), overweight (25-29.9), and obesity classes I through III, with body silhouettes showing progressive fat accumulation and preferential visceral versus subcutaneous distribution patterns. Panel B: Adipose tissue inflammation diagram showing adipocyte hypertrophy, crown-like structures of macrophages around dying adipocytes, M1 macrophage predominance, and secretion of TNF-alpha, IL-6, and reduced adiponectin. Panel C: Metabolic syndrome components illustrated as interconnected circle including central obesity (waist circumference), hypertriglyceridemia, low HDL, elevated blood pressure, and fasting hyperglycemia with insulin resistance as central mechanism. Panel D: NAFLD spectrum progression from normal liver to simple steatosis with fat droplets, to NASH with hepatocyte ballooning and inflammation, to cirrhosis with fibrosis and regenerative nodules.</image>

Summary

• Environmental toxins produce injury through multiple mechanisms including free radical generation, direct damage, enzyme inhibition, and DNA damage, with toxicity determined by dose, duration, route, and individual susceptibility factors
• Pneumoconioses result from inhaled particles 1-5 micrometers reaching alveoli, with silicosis producing fibrotic nodules and eggshell calcification, coal worker's pneumoconiosis progressing from macules to progressive massive fibrosis
• Asbestos exposure causes interstitial fibrosis (asbestosis), pleural plaques, and malignant mesothelioma, with characteristic ferruginous bodies and multiplicative cancer risk with smoking
• Lead toxicity produces cognitive impairment in children, peripheral neuropathy in adults, microcytic anemia with basophilic stippling, and abdominal colic
• Alcohol metabolism generates acetaldehyde and causes NAD+ depletion, producing liver disease spectrum from steatosis to alcoholic hepatitis (Mallory bodies) to cirrhosis
• Smoking causes lung cancer (10-20x risk), COPD through protease-antiprotease imbalance, and cardiovascular disease through endothelial dysfunction and atherogenesis
• Acetaminophen toxicity results from NAPQI accumulation when glutathione is depleted, causing centrilobular hepatic necrosis; N-acetylcysteine is the antidote
• Fat-soluble vitamin deficiencies: A (night blindness, xerophthalmia), D (rickets, osteomalacia), E (spinocerebellar degeneration), K (bleeding diathesis)
• Water-soluble vitamin deficiencies: B1 (beriberi, Wernicke-Korsakoff), B3 (pellagra with 4 Ds), B12 (megaloblastic anemia, subacute combined degeneration), C (scurvy)
• Protein-energy malnutrition includes marasmus (total caloric deficit, wasting) and kwashiorkor (protein deficit, edema, fatty liver)
• Obesity produces chronic inflammation through adipose tissue dysfunction, leading to metabolic syndrome, NAFLD, type 2 diabetes, and increased cancer risk

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown